Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (3y) (2015 - 2026)
Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 91.84 Bn | 89.98 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.37 Bn | 32.63 Bn | 1.97 Bn | - |
| 3 | Zoetis | 33.09 Bn | 31.15 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.83 Bn | 23.77 Bn | 4.39 Bn | 39.72% |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 21.11 Bn | 21.11 Bn | - | - |
| 7 | Viatris | 20.58 Bn | 18.77 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 18.02 Bn | 16.70 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.80 Bn | 12.37 Bn | 785.00 Mn | 41.72% |
| 10 | Sunshine Biopharma | 740,796.94 | -6.17 Mn | 2.18 Mn | 24.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.07% |
| Sep 30, 2025 | 98.12% |
| Mar 31, 2025 | 55.60% |
| Dec 31, 2024 | -502.84% |
| Sep 30, 2024 | -0.18% |
| Jun 30, 2024 | -84.01% |
| Mar 31, 2024 | 20.18% |
| Dec 31, 2023 | -168.27% |
| Sep 30, 2023 | -32.46% |
| Jun 30, 2023 | -19.31% |
| Mar 31, 2023 | -97.10% |
| Dec 31, 2022 | -244.13% |
| Sep 30, 2022 | -4,805.47% |
| Mar 31, 2022 | -211.92% |
| Dec 31, 2021 | -10.88% |
| Sep 30, 2021 | 9.00% |
| Jun 30, 2021 | 56.54% |
| Mar 31, 2021 | -126.48% |
| Dec 31, 2020 | -8.45% |
| Sep 30, 2020 | 9.80% |